ACXP · Acurx Pharmaceuticals, Inc.
AI read · Neutral
The AI's read
The filing gives no sign of a change to Acurx's operations, finances, or plans. A board seat is now vacant, but no business consequence is reported.
Acurx reported a director's death, leaving a board seat vacant. The filing reports no change to its business, so its outlook remains unchanged.
The filing gives no sign of a change to Acurx's operations, finances, or plans. A board seat is now vacant, but no business consequence is reported.
Follow Acurx Pharmaceuticals, Inc. (ACXP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ACXP